Gene · 701
Papers3,969
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 3,969
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dissecting super-enhancer driven transcriptional dependencies reveals novel therapeutic strategies and targets for group 3 subtype medulloblastoma. | J Exp Clin Cancer Res | 2022 | 36273157 | PubTator, text mining | PubMed |
| Mining Database to Identify Aging-Related Molecular Subtype and Prognostic Signature in Lung Adenocarcinoma. | J Oncol | 2022 | 36268280 | PubTator, text mining | PubMed |
| Nanomaterial-assisted CRISPR gene-engineering - A hallmark for triple-negative breast cancer therapeutics advancement. | Mater Today Bio | 2022 | 36267139 | PubTator, text mining | PubMed |
| GPI: An indicator for immune infiltrates and prognosis of human breast cancer from a comprehensive analysis. | Front Endocrinol (Lausanne) | 2022 | 36246907 | PubTator, text mining | PubMed |
| Identification of the Key Genes Involved in the Tumorigenesis and Prognosis of Prostate Cancer. | Comput Math Methods Med | 2022 | 36245843 | PubTator, text mining | PubMed |
| Investigation of Transcriptome Patterns in Endometrial Cancers from Obese and Lean Women. | Int J Mol Sci | 2022 | 36232772 | PubTator, text mining | PubMed |
| Female Germ Cell Development in Chickens and Humans: The Chicken Oocyte Enriched Genes Convergent and Divergent with the Human Oocyte. | Int J Mol Sci | 2022 | 36232712 | PubTator, text mining | PubMed |
| Anoikis-Associated Lung Cancer Metastasis: Mechanisms and Therapies. | Cancers (Basel) | 2022 | 36230714 | PubTator, text mining | PubMed |
| Sirtfoods: New Concept Foods, Functions, and Mechanisms. | Foods | 2022 | 36230032 | PubTator, text mining | PubMed |
| Construction of novel lncRNA-miRNA-mRNA ceRNA networks associated with prognosis of hepatitis C virus related hepatocellular carcinoma. | Heliyon | 2022 | 36217480 | PubTator, text mining | PubMed |
| Identification of Prognostic Markers and Potential Therapeutic Targets in Gastric Adenocarcinoma by Machine Learning Based on mRNAsi Index. | J Oncol | 2022 | 36213825 | PubTator, text mining | PubMed |
| A single administration of hIL-7-hyFc induces long-lasting T-cell expansion with maintained effector functions. | Blood Adv | 2022 | 36206199 | PubTator, text mining | PubMed |
| Bioinformatics and network-based screening and discovery of potential molecular targets and small molecular drugs for breast cancer. | Front Pharmacol | 2022 | 36204232 | PubTator, text mining | PubMed |
| Analysis and identification of potential type II helper T cell (Th2)-Related key genes and therapeutic agents for COVID-19. | Comput Biol Med | 2022 | 36201886 | PubTator, text mining | PubMed |
| Screening of the Key Genes for the Progression of Liver Cirrhosis to Hepatocellular Carcinoma Based on Bioinformatics. | J Oncol | 2022 | 36199789 | PubTator, text mining | PubMed |
| Bioinformatic identification of differentially expressed genes associated with hepatocellular carcinoma prognosis. | Medicine (Baltimore) | 2022 | 36197270 | PubTator, text mining | PubMed |
| Hyper-active RAS/MAPK introduces cancer-specific mitotic vulnerabilities. | Proc Natl Acad Sci U S A | 2022 | 36191188 | PubTator, text mining | PubMed |
| HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans. | Clin Cancer Res | 2022 | 36190432 | PubTator, text mining | PubMed |
| Dissecting novel mechanisms of hepatitis B virus related hepatocellular carcinoma using meta-analysis of public data. | World J Gastrointest Oncol | 2022 | 36187396 | PubTator, text mining | PubMed |
| ASPM, CDC20, DLGAP5, BUB1B, CDCA8, and NCAPG May Serve as Diagnostic and Prognostic Biomarkers in Endometrial Carcinoma. | Genet Res (Camb) | 2022 | 36186000 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/701/papers?page=31